Sermonix Pharmaceuticals Inc.

This study tested whether an oral pill called lasofoxifene could work as well as or better than the standard injection (fulvestrant) for women with a specific type of advanced breast cancer. It focused on women whose cancer had stopped responding to other hormone therapies and ha…